Active — Not RecruitingNot Applicable

Advanced Diffusion Imaging in Renal Cancer Patients

United States39 participantsStarted 2022-12-01

Plain-language summary

The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.

Who can participate

Age range21 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Renal mass patients scheduled for laparoscopic partial nephrectomy. * eGFR above 30 ml/min/m2. * Ages 21 to 85 * Must be willing and able to provide consent. Exclusion Criteria: * All metal implants and dental implants that have ferromagnetic properties and are unsafe at 3.0 T. * Pregnant women are not eligible for participating in this study. * Acute claustrophobia

What they're measuring

Percentage of Times Lesion Type is Correctly Predicted using IVIM-MRI at Pre-Surgery

Timeframe: Baseline (1 Week Prior to Operation)

Trial details

NCT IDNCT06116253

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-12-01

View on ClinicalTrials.gov More Renal Cancer trials